Matthew Schroeder
Physician Assistant · Orange City, FLNPI 1063730687
Payments from drug & device makers
Across 33 payments — averaging $172.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$5K
- AbbVie$197
- Strata Skin Sciences, Inc.$160
- Sanofi-aventis U.S. LLC$100
- Teva Pharmaceuticals USA, Inc.$91
- Sanofi$88
- plus $160 from 8 others
What the payments were for
- Speaking & faculty fees$3,05054%
- Travel & lodging$1,27923%
- Food & beverage$1,15820%
- Education$1913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 9 | $4,882 |
| AbbVie | 7 | $197 |
| Strata Skin Sciences, Inc. | 3 | $160 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Teva Pharmaceuticals USA, Inc. | 1 | $91 |
| Sanofi | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Almirall LLC | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Novartis | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,678 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 74 | $2,478 |
| Permethrin | 27 | $2,028 |
| Clobetasol Propionate | 27 | $1,424 |
| Betamethasone Dipropionate | 24 | $1,244 |
| Ammonium Lactate | 38 | $1,135 |
| Mometasone Furoate | 25 | $932 |
| Mupirocin | 46 | $377 |
| Triamcinolone Acetonide | 21 | $284 |
| Fluconazole | 13 | $181 |
| Hydroxyzine Hcl | 13 | $144 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $73 |
| Cephalexin | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Orange City
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.